Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Oragenics, Inc. SVP of Discovery Research, Martin Handfield, Ph.D. to Be Featured Speaker at the International Conference on Microbial Research and Applications


Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announces the company's Senior Vice President of Discovery Research, Martin Handfield, MS, Ph.D., will be a featured speaker at the inaugural International Conference on Microbial Research and Applications (MicroBiome 2019).

Dr. Handfield will be speaking on November 13, 2019 at 12:20PM ET. The International Conference on Microbial Research and Applications will be held November 13-14, 2019 at the Radisson Hotel, Downton-Inner Harbor in Baltimore, Md. Dr. Handfield's talk will be titled, "Lantibiotics: a large untapped pipeline of attractive scaffolds for the development of novel antibiotics." Those interested in attending the talk may register for the conference via its website, https://unitedscientificgroup.com/conferences/microbiology-research/.

About Lantibiotics

Lantibiotics are a class of antibiotic compounds with novel mechanism of action, prized for their ability to overcome antibiotic-resistant infections. With resistant strains on the rise, particularly healthcare-acquired infections (HAI), the need for these potent lantibiotic agents is critical. Oragenics is pursuing the commercial-scale production of a lantibiotic for use as an antimicrobial.

About Oragenics, Inc.

We are focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics, Inc. has established two exclusive worldwide channel collaborations with Intrexon Corporation and its subsidiaries. The collaborations allow Oragenics to accelerate the development of much needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat, and esophagus.

For more information about Oragenics, please visit www.oragenics.com.

Safe Harbor Statement: Under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements that reflect management's current views with respect to future events and performance. These forward-looking statements are based on management's beliefs and assumptions and information currently available. The words "believe," "expect," "anticipate," "intend," "estimate," "project" and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include, but are not limited to, risks and uncertainties described in our filings with the U.S. Securities and Exchange Commission. Oragenics assumes no responsibility to update any forward-looking statements contained in this press release or with respect to the matters described herein.


These press releases may also interest you

at 00:40
As a leading global supplier of mobile communication and IoT chipsets, UNISOC announces today that 8521E for smart watches is powering the Xiaomi Mi Kids Watch 4. With high integration, high performance and low power consumption, UNISOC 8521E...

at 00:37
ZTE Corporation (0763.HK / 000063.SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, today has helped the Zhejiang branch of China Mobile send China's first 5G message...

at 00:00
In the latest recognition in Geospatial Industry Expertise, INCATech receives the Federal Small Business Specialty Award, Delivery Partner from Esri® for consistent engagement and excellence in delivering Esri® projects/programs for key customers at...

9 avr 2020
There has been a lot of talk about ventilators and N95 masks, but CRIMADI has observed the reality is that healthcare workers are struggling with a much longer list of shortages every day. And feeling helpless in being able to save as many lives as...

9 avr 2020
The Honourable Seamus O'Regan, Canada's Minister of Natural Resources, will hold a media teleconference following his participation in a virtual G20 Energy Ministers meeting. Date: Friday, April 10, 2020Time: 2:30 p.m. EDT Media representatives...

9 avr 2020
Samsung Biologics (207940.KS) and Vir Biotechnology, Inc. today announced a manufacturing agreement under which Samsung Biologics will perform large scale manufacturing services for Vir's SARS-CoV-2 monoclonal antibody (mAb) program. "We are proud...



News published on 11 november 2019 at 10:25 and distributed by: